| scholarly article | Q13442814 |
| P50 | author | Frederick R. Appelbaum | Q75025725 |
| C. Dean Buckner | Q75039324 | ||
| P2093 | author name string | W I Bensinger | |
| F B Petersen | |||
| E Bryant | |||
| C Anasetti | |||
| P Beatty | |||
| R A Clift | |||
| L D Fisher | |||
| S I Bearman | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chronic myeloid leukemia | Q729735 |
| myeloid leukemia | Q11688946 | ||
| P304 | page(s) | 1660-1665 | |
| P577 | publication date | 1991-04-01 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: a randomized trial of two irradiation regimens | |
| P478 | volume | 77 |
| Q35849468 | 131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission. |
| Q47880234 | A comparison of the biodistribution and biokinetics of (99m)Tc-anti-CD66 mAb BW 250/183 and (99m)Tc-anti-CD45 mAb YTH 24.5 with regard to suitability for myeloablative radioimmunotherapy |
| Q37420496 | Acute graft-versus-host disease: from the bench to the bedside |
| Q33560410 | Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome |
| Q35964204 | Allogeneic hematopoietic cell transplantation: from experimental biology to clinical care |
| Q40483853 | An acute graft-versus-host disease activity index to predict survival after hematopoietic cell transplantation with myeloablative conditioning regimens |
| Q34612119 | Anti-CD45 radioimmunotherapy with 90Y but not 177Lu is effective treatment in a syngeneic murine leukemia model |
| Q36488985 | Anti-CD45 radioimmunotherapy without TBI before transplantation facilitates persistent haploidentical donor engraftment |
| Q30679410 | CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia |
| Q51534963 | CT-based analysis of dose homogeneity in total body irradiation using lateral beam. |
| Q34360641 | Comparison of reduced-intensity and myeloablative conditioning regimens for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia and acute lymphoblastic leukemia: a meta-analysis |
| Q36819337 | Dissecting graft-versus-leukemia from graft-versus-host-disease using novel strategies |
| Q50660084 | Dose Escalation of Total Marrow Irradiation in High-Risk Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. |
| Q35032266 | Dose escalation of total marrow irradiation with concurrent chemotherapy in patients with advanced acute leukemia undergoing allogeneic hematopoietic cell transplantation |
| Q35859239 | Efficiency of high-dose cytarabine added to CY/TBI in cord blood transplantation for myeloid malignancy. |
| Q36445890 | Eradication of disseminated leukemia in a syngeneic murine leukemia model using pretargeted anti-CD45 radioimmunotherapy. |
| Q60044551 | Feasibility of a novel dose fractionation strategy in TMI/TMLI |
| Q37496060 | Image-guided total-marrow irradiation using helical tomotherapy in patients with multiple myeloma and acute leukemia undergoing hematopoietic cell transplantation |
| Q39651929 | In-vivo dosimetry with Gafchromic films for multi-isocentric VMAT irradiation of total marrow lymph-nodes: a feasibility study |
| Q37296965 | Low relapse without excessive transplant-related mortality following myeloablative cord blood transplantation for acute leukemia in complete remission: a matched cohort analysis |
| Q33861150 | Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemia |
| Q35268812 | Multi-institutional feasibility study of a fast patient localization method in total marrow irradiation with helical tomotherapy: a global health initiative by the international consortium of total marrow irradiation |
| Q35605318 | NCI First International Workshop on The Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: report from the committee on prevention of relapse following allogeneic cell transplantation for hematologic ma |
| Q83186138 | NCI first International Workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on the biological considerations of hematological relapse following allogeneic |
| Q64971135 | National survey of myeloablative total body irradiation prior to hematopoietic stem cell transplantation in Japan: survey of the Japanese Radiation Oncology Study Group (JROSG). |
| Q41995096 | Neurocognitive Dysfunction in Hematopoietic Cell Transplant Recipients: Expert Review From the Late Effects and Quality of Life Working Committee of the CIBMTR and Complications and Quality of Life Working Party of the EBMT. |
| Q48222982 | Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT. |
| Q37644054 | Optimising the conditioning regimen for acute myeloid leukaemia |
| Q33771667 | Optimizing reduced-intensity conditioning regimens for myeloproliferative neoplasms |
| Q37248813 | Peripheral dose heterogeneity due to the thread effect in total marrow irradiation with helical tomotherapy. |
| Q34568898 | Phase 1/2 trial of total marrow and lymph node irradiation to augment reduced-intensity transplantation for advanced hematologic malignancies |
| Q46250890 | Phase I Trial of Total Marrow and Lymphoid Irradiation Transplantation Conditioning in Patients with Relapsed/Refractory Acute Leukemia |
| Q34113941 | Pretargeted radioimmunotherapy for hematologic and other malignancies |
| Q46642358 | Radioimmunotherapy with [188Re]-labelled anti-CD66 antibody in the conditioning for allogeneic stem cell transplantation for high-risk acute myeloid leukemia |
| Q34022682 | Radiolabeled anti-CD45 antibody with reduced-intensity conditioning and allogeneic transplantation for younger patients with advanced acute myeloid leukemia or myelodysplastic syndrome |
| Q38095962 | Radiolabeled antibodies directed at CD45 for conditioning prior to allogeneic transplantation in acute myeloid leukemia and myelodysplastic syndrome |
| Q35075792 | Suberoylanilide hydroxamic acid induces hypersensitivity to radiation therapy in acute myelogenous leukemia cells expressing constitutively active FLT3 mutants |
| Q37202971 | Successful management of multifactorial colitis in a recipient of hematopoietic stem cell transplant: a case report. |
| Q37288650 | Targeting myeloid cells to the brain using non-myeloablative conditioning |
| Q38039703 | The road to purified hematopoietic stem cell transplants is paved with antibodies. |
| Q91859903 | The role of allogeneic stem cell transplantation in the management of acute myeloid leukaemia: a triumph of hope and experience |
| Q37443163 | Total Body Irradiation without Chemotherapy as Conditioning for an Allogeneic Hematopoietic Cell Transplantation for Adult Acute Myeloid Leukemia |
| Q42181801 | Total marrow irradiation as part of autologous stem cell transplantation for Asian patients with multiple myeloma. |
| Q50905008 | Total-body irradiation before bone marrow transplantation for acute leukemia in first or second complete remission. Results and prognostic factors in 326 consecutive patients. |
Search more.